发明名称 |
Prevention and treatment of thromboembolic disorders |
摘要 |
The present invention relates to the field of blood coagulation, more specifically it relates to a method of treating a thromboembolic disorder by administering once daily a direct factor Xa inhibitor in oral dosage form to a patient in need thereof, wherein the factor Xa inhibitor has a plasma concentration half life indicative of a bid or tid administration interval, e.g. of 10 hours or less. |
申请公布号 |
ZA200706238(B) |
申请公布日期 |
2008.11.26 |
申请号 |
ZA20070006238 |
申请日期 |
2007.07.27 |
申请人 |
BAYER HEALTHCARE AG. |
发明人 |
MISSELWITZ, FRANK;KUBITZA, DAGMAR;PARK, SON-MI;WEHLING, KLAUS |
分类号 |
A61K;A61P |
主分类号 |
A61K |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|